Breaking Kansas Voters to Decide on Gubernatorial Appointment vs. Popular Election for State Supreme Court Justices Trump Halts Further Strikes Against Iran Amid Emerging Deal Red Sox Edge Dodgers 3-2 Behind Rafaela’s Two Home Runs Pittsburgh Pirates Acquire Reliever Camilo Doval in Trade with New York Yankees Women’s Professional Baseball League Kicks Off Inaugural Season Amidst Enthusiastic Debut

Sunday August 2, 2026

Reporter

Kelun-Biotech

4Articles Published

4Communities Covered

Published Articles

Press Release

NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC

Jul 30

Press Release

Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565

Jul 27

Press Release

Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma

Jul 15

Press Release

Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint

Jul 14